205 related articles for article (PubMed ID: 33748487)
1. Association between
Ulhaq ZS; Soraya GV; Milliana A; Tse WKF
Heliyon; 2021 Mar; 7(3):e06428. PubMed ID: 33748487
[TBL] [Abstract][Full Text] [Related]
2. G-protein-coupled estrogen receptor-30 gene polymorphisms are associated with uterine leiomyoma risk.
Kasap B; Öztürk Turhan N; Edgünlü T; Duran M; Akbaba E; Öner G
Bosn J Basic Med Sci; 2016 Jan; 16(1):39-45. PubMed ID: 26773178
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants of GPER/GPR30, a novel estrogen-related G protein receptor, are associated with human seminoma.
Chevalier N; Paul-Bellon R; Camparo P; Michiels JF; Chevallier D; Fénichel P
Int J Mol Sci; 2014 Jan; 15(1):1574-89. PubMed ID: 24451139
[TBL] [Abstract][Full Text] [Related]
4. GPR30 Gene Polymorphisms Are Associated with Gynecomastia Risk in Adolescents.
Korkmaz HA; Edgünlü T; Eren E; Demir K; Çakir ED; Çelik SK; Özkan B
Horm Res Paediatr; 2015; 83(3):177-82. PubMed ID: 25531203
[TBL] [Abstract][Full Text] [Related]
5. Expression and Role of the G Protein-Coupled Estrogen Receptor (GPR30/GPER) in the Development and Immune Response in Female Reproductive Cancers.
Hernández-Silva CD; Villegas-Pineda JC; Pereira-Suárez AL
Front Endocrinol (Lausanne); 2020; 11():544. PubMed ID: 32973677
[TBL] [Abstract][Full Text] [Related]
6. Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology.
Filardo EJ; Thomas P
Endocrinology; 2012 Jul; 153(7):2953-62. PubMed ID: 22495674
[TBL] [Abstract][Full Text] [Related]
7. The G protein-coupled estrogen receptor (GPER/GPR30) may serve as a prognostic marker in early-stage cervical cancer.
Friese K; Kost B; Vattai A; Marmé F; Kuhn C; Mahner S; Dannecker C; Jeschke U; Heublein S
J Cancer Res Clin Oncol; 2018 Jan; 144(1):13-19. PubMed ID: 28924735
[TBL] [Abstract][Full Text] [Related]
8. GPR30 gene polymorphisms are associated with progesterone receptor status and histopathological characteristics of breast cancer patients.
Giess M; Lattrich C; Springwald A; Goerse R; Ortmann O; Treeck O
J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):7-12. PubMed ID: 19744559
[TBL] [Abstract][Full Text] [Related]
9. The G-protein-coupled estrogen receptor, a gene co-expressed with ERα in breast tumors, is regulated by estrogen-ERα signalling in ERα positive breast cancer cells.
Pal U; Manjegowda MC; Singh N; Saikia S; Philip BS; Jyoti Kalita D; Kumar Rai A; Sarma A; Raphael V; Modi D; Chandra Kataki A; Mukund Limaye A
Gene; 2023 Aug; 877():147548. PubMed ID: 37279863
[TBL] [Abstract][Full Text] [Related]
10. The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis.
Talia M; De Francesco EM; Rigiracciolo DC; Muoio MG; Muglia L; Belfiore A; Maggiolini M; Sims AH; Lappano R
Cells; 2020 Mar; 9(3):. PubMed ID: 32143514
[TBL] [Abstract][Full Text] [Related]
11. Genomic polymorphisms of G-protein estrogen receptor 1 are associated with severity of adolescent idiopathic scoliosis.
Peng Y; Liang G; Pei Y; Ye W; Liang A; Su P
Int Orthop; 2012 Mar; 36(3):671-7. PubMed ID: 22002330
[TBL] [Abstract][Full Text] [Related]
12. G-protein-coupled estrogen receptor GPER-1 expression in hormone receptor-positive breast cancer is associated with poor benefit of tamoxifen.
Ignatov T; Claus M; Nass N; Haybaeck J; Seifert B; Kalinski T; Ortmann O; Ignatov A
Breast Cancer Res Treat; 2019 Feb; 174(1):121-127. PubMed ID: 30478785
[TBL] [Abstract][Full Text] [Related]
13. G protein-coupled estrogen receptor (GPER) expression in endometrial adenocarcinoma and effect of agonist G-1 on growth of endometrial adenocarcinoma cell lines.
Skrzypczak M; Schüler S; Lattrich C; Ignatov A; Ortmann O; Treeck O
Steroids; 2013 Nov; 78(11):1087-91. PubMed ID: 23921077
[TBL] [Abstract][Full Text] [Related]
14. Conserved estrogen binding and signaling functions of the G protein-coupled estrogen receptor 1 (GPER) in mammals and fish.
Thomas P; Alyea R; Pang Y; Peyton C; Dong J; Berg AH
Steroids; 2010; 75(8-9):595-602. PubMed ID: 19931550
[TBL] [Abstract][Full Text] [Related]
15. MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells.
Lappano R; Santolla MF; Pupo M; Sinicropi MS; Caruso A; Rosano C; Maggiolini M
Breast Cancer Res; 2012 Jan; 14(1):R12. PubMed ID: 22251451
[TBL] [Abstract][Full Text] [Related]
16. GPER and Testicular Germ Cell Cancer.
Chevalier N; Hinault C; Clavel S; Paul-Bellon R; Fenichel P
Front Endocrinol (Lausanne); 2020; 11():600404. PubMed ID: 33574796
[TBL] [Abstract][Full Text] [Related]
17. Enhanced expression of G-protein coupled estrogen receptor (GPER/GPR30) in lung cancer.
Jala VR; Radde BN; Haribabu B; Klinge CM
BMC Cancer; 2012 Dec; 12():624. PubMed ID: 23273253
[TBL] [Abstract][Full Text] [Related]
18. The G-protein coupled estrogen receptor (GPER/GPR30) is a gonadotropin receptor dependent positive prognosticator in ovarian carcinoma patients.
Heublein S; Mayr D; Vrekoussis T; Friese K; Hofmann SS; Jeschke U; Lenhard M
PLoS One; 2013; 8(8):e71791. PubMed ID: 23951246
[TBL] [Abstract][Full Text] [Related]
19. Twenty years of the G protein-coupled estrogen receptor GPER: Historical and personal perspectives.
Barton M; Filardo EJ; Lolait SJ; Thomas P; Maggiolini M; Prossnitz ER
J Steroid Biochem Mol Biol; 2018 Feb; 176():4-15. PubMed ID: 28347854
[TBL] [Abstract][Full Text] [Related]
20. Lack of G protein-coupled estrogen receptor (GPER) in the plasma membrane is associated with excellent long-term prognosis in breast cancer.
Sjöström M; Hartman L; Grabau D; Fornander T; Malmström P; Nordenskjöld B; Sgroi DC; Skoog L; Stål O; Leeb-Lundberg LM; Fernö M
Breast Cancer Res Treat; 2014 May; 145(1):61-71. PubMed ID: 24715381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
